GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
04 avr. 2024 12h30 HE
|
GeoVax, Inc.
Presentation Made During the 24th Annual World Vaccine Congress ATLANTA, GA, April 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company...
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
06 mars 2024 09h00 HE
|
GeoVax, Inc.
Manufacturing Process for Phase 3 and Commercial Production Being Developed for GeoVax MVA-Based Vaccines ATLANTA, GA, March 06, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc....
DHSS launches interactive statewide flu dashboard
13 oct. 2023 17h00 HE
|
Missouri Department of Health and Senior Services
JEFFERSON CITY, Mo., Oct. 13, 2023 (GLOBE NEWSWIRE) -- The Missouri Department of Health and Senior Services (DHSS) has published the first Weekly Influenza Surveillance Report of the 2023-2024 flu...
COVID-19 Vaccine Market Predicted to Reach USD 9.9 billion by 2031, Garnering -13.6% CAGR: TMR Report
14 sept. 2023 09h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The COVID-19 vaccine market was estimated to have acquired US$ 92.6 billion in 2021. It is...
FFF Enterprises Inc. Adds COVID-19 Vaccines and Respiratory Syncytial Virus (RSV) Products to Its Comprehensive, Expanding Portfolio
13 sept. 2023 13h34 HE
|
FFF Enterprises.com
TEMECULA, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- FFF Enterprises Inc., recognized as the nation's most trusted specialty drug distributor and diversified healthcare company, has partnered with...
GeoVax Partners With ABL to Advance cGMP Production of Vaccine Candidates
31 mai 2023 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, May 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious...
GeoVax’s Next-Generation COVID-19 Vaccine Shows High Immunogenicity in Immunocompromised Patients
24 mai 2023 08h00 HE
|
GeoVax, Inc.
New and Unpublished Data from Phase 2 Open-Label Safety Study ofGEO-CM04S1 Presented at Two Recent Scientific Meetings ATLANTA, GA, May 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs,...
‘Negative Evidence’ on COVID-19 Vaccines and Cancer Reviewed in the Journal of American Physicians and Surgeons (AAPS)
21 mars 2023 11h32 HE
|
Association of American Physicians and Surgeons
TUCSON, Ariz., March 21, 2023 (GLOBE NEWSWIRE) -- Given the dread that the thought of cancer inspires, and anecdotal reports of cancer manifesting soon after a COVID-19 vaccination, the lack of...
King Faisal Prize Awards $1 Million, in Recognition of COVID-19 Vaccine Development, Nanotechnology Ingenuity Contributing to 100 Scientific Breakthroughs that Changed the World, and other Key Scientific & Humanitarian Achievements
20 mars 2023 15h22 HE
|
King Faisal Prize
Riyadh, Saudi Arabia, March 20, 2023 (GLOBE NEWSWIRE) -- On 20 March, Harvard University and Oxford University professors Dan Barouch from the US and Sarah Gilbert from the UK received the King...
GeoVax Congratulates Don Diamond, Ph.D. as Finalist for Vaccine Industry Excellence Award at World Vaccine Congress
15 mars 2023 09h00 HE
|
GeoVax, Inc.
Dr. Diamond and City of Hope COVID-19 Vaccine Team Nominated forBest Academic/Research Team Award ATLANTA, GA, March 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq:...